Skip to main content

Greifswald to Use InforSense Software for Genotyping Study

NEW YORK (GenomeWeb News) – InforSense said today that the University of Greifswald is using its GenSense software platform to handle quality control, analysis, and annotation for a genotyping study of the causes of various diseases.

The University, located in Germany's Baltic Sea region, will use the software to analyze data from study of 4,100 individuals who were genotyped with the Affymetrix Genome-Wide Human SNP Array 6.0.

The Study of Health in Pomerania, which includes phenotype data, is aimed at finding the genetic causes of complex diseases, including the susceptibility loci for several common diseases.

The GenSense platform enables customers to "automate their genotypic analysis and quality control and improve productivity, especially when data needs to be repeatedly reformatted and transformed for use with different studies and tools," Jonathan Sheldon, InforSense's chief scientific officer, said in a statement.

Financial terms of the agreement were not released.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.